mTOR-Driven Aging and Rapamycin with Mikhail Blagosklonny and Dennis Mangan [SHORT VERSION]

Dr. Mikhail Blagosklonny is a professor of oncology who now studies aging, and is the originator of the hyperfunction theory of aging. He has written numerous scientific articles on aging and, in particular, on the extension of lifespan with rapamycin. Here, he and Dennis Mangan discuss how Dr. Blagosklonny's cancer research led him to the study of aging, whether rapamycin is the most important anti-aging intervention currently available, his skepticism about metformin as an anti-aging drug, and more. Video transcript: https://aging-us.net/2022/06/15/interview-mtor-driven-aging-and-rapamycin/ In remembrance of Dr. Blagosklonny: https://www.aging-us.com/mikhail-blagosklonny Keywords: rapamycin, mTOR, aging, longevity, oncology To learn more about Aging, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM